Regulatory
FDA facing rising pressure to exercise CBD ‘enforcement discretion’
Regulatory
FDA facing rising pressure to exercise CBD ‘enforcement discretion’FDA facing rising pressure to exercise CBD ‘enforcement discretion’
Lawmakers seek a policy of enforcement discretion but that wouldn’t address the underlying problem facing the hemp industry—namely FDA’s position that CBD cannot be marketed in a dietary supplement.
Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.